What role for topical antibacterials in acne?

Drug and Therapeutics Bulletin

Volumn 48, Issue 12, 2010, Pages 141-144

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZELAIC ACID; BENZAMYCIN; BENZOYL PEROXIDE; CLINDAMYCIN; ERYTHROMYCIN; ISOTRETINOIN; MINOCYCLINE; OXYTETRACYCLINE; RETINOIC ACID;

ACNE VULGARIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; DISEASE SEVERITY; DRUG EFFECT; HUMAN; MONOTHERAPY; PROPIONIBACTERIUM ACNES; REVIEW; TOPICAL TREATMENT;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; HUMANS; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME;

EID: 79952667399     PISSN: 00126543     EISSN: 17555248     Source Type: Journal    
DOI: 10.1136/dtb.2010.12.0062     Document Type: Review

References (17)

1. The NHS Information Centre, 2010. Prescription cost analysis: England 2009 [online]. Available: http://www.ic.nhs.uk/webfiles/publications/ prescostanalysis2009/PCA-2009.pdf [Accessed 18 November 2010].
2. Layton A. Disorders of the sebaceous glands. In: Burns DA et al (Eds). Rook's Textbook of Dermatology. Eighth edition. London: Blackwell Publishing, 2010.
3. Garner SE. Acne vulgaris. In: Williams H (Ed). Evidence Based Dermatology. London: BMJ, 2003.
4. Schofield JK et al. Skin conditions in the UK: a health care needs assessment. First edition. Nottingham: Centre of Evidence Based Dermatology, 2009.
5. Smithard A et al. Acne prevalence, knowledge about acne and psychological morbidity in mid-adolescence: a community-based study. Br J Dermatol 2001; 145: 274-9. (Pubitemid 32955354)
6. Strauss JS et al. Guidelines of care for acne vulgaris management. J Am Acad Dermatol 2007; 56: 651-63. (Pubitemid 46400177)
7. Tan JKL. Current measures for the evaluation of acne severity. Expert Rev Dermatol 2008; 3: 595-603.
8. Thiboutot D et al. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne Group. J Am Acad Dermatol 2009: 60: S1-50.
9. Clinical Knowledge Summaries. Acne vulgaris [online]. Available: http://www.cks.nhs.uk/acne-vulgaris [Accessed 18 November 2010].
10. Goulden V. Guidelines for the management of Acne vulgaris in adolescents. Paediatr Drugs 2003; 5: 301-13. (Pubitemid 36629713)
11. Joint Formulary Committee. British National Formulary. Edition 60. London: BMJ Group and RPS Publishing, September 2010.
12. Leyden JJ. Therapy for acne vulgaris. N Engl J Med 1997; 336: 1156-62.
13. Lehmann HP et al. Management of Acne. Agency for Healthcare Research and Quality - Evidence reports/technology assessments no.17 [online]. Available: www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=erta17 [Accessed 18 November 2010].
14. Ozolins M et al. Randomised controlled multiple treatment comparison to provide a cost effectiveness rationale for the selection of antimicrobial therapy in acne. Health Technology Assessment 2005; 9: iii-212.
15. Lookingbill DP et al. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined with results of two double-blind investigations. J Am Acad Dermatol 1997; 37: 590-5.
16. Leyden JF et al. The efficacy and safety of a combination benzoyl peroxide/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide/erythromycin combination product. J Cutan Med Surg 2001; 5: 37-42.
17. Simonart T, Dramaix M. Treatment of acne with topical antibiotics: lessons from clinical studies. Br J Dermatol 2005; 153: 395-403.